TSE:7774Biotechs
Japan Tissue Engineering Q3 Loss Deepens To ¥4.56 EPS And Tests Profitability Narrative
Japan Tissue Engineering (TSE:7774) has just posted its Q3 2026 numbers, with revenue of ¥511 million and a net loss of ¥185 million, which translated into EPS of ¥4.56 in the red, setting the tone for another loss-making quarter. The company has seen quarterly revenue move between ¥511 million and ¥748.58 million since Q2 2025, while EPS has swung from a profit of ¥2.34 per share in Q4 2025 to losses such as ¥5.97 in Q1 2026, so investors are watching how these results feed into the broader...